Cargando…
Quantifying the COVID‐19 endgame: Is a new normal within reach?
Eradication of COVID‐19 is out of reach. Are we close to a “new normal” in which people can leave behind restrictive non‐pharmaceutical interventions (NPIs) yet face a tolerable burden of disease? The answer depends on the ongoing risks versus communities' tolerance for those risks. Using a det...
Autores principales: | Rahmandad, Hazhir, Sterman, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538382/ https://www.ncbi.nlm.nih.gov/pubmed/36246868 http://dx.doi.org/10.1002/sdr.1715 |
Ejemplares similares
-
Behavioral responses to risk promote vaccinating high‐contact individuals first
por: Rahmandad, Hazhir
Publicado: (2022) -
COVID-19 vaccine immunogenicity in people with HIV
por: Costiniuk, Cecilia T., et al.
Publicado: (2023) -
COVID-19 in the United States: Trajectories and second surge behavior
por: James, Nick, et al.
Publicado: (2020) -
Forecasting the daily and cumulative number of cases for the COVID-19 pandemic in India
por: Khajanchi, Subhas, et al.
Publicado: (2020) -
Cluster-based dual evolution for multivariate time series: Analyzing COVID-19
por: James, Nick, et al.
Publicado: (2020)